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Introduction. In this retrospective study we evaluated the multimodal visualization of retinal genetic diseases to better understand
their natural course. Material and Methods. We reviewed the charts of 70 consecutive patients with different genetic retinal
pathologies who had previously undergone multimodal imaging analyses. Genomic DNA was extracted from peripheral blood
and genotyped at the known locus for the different diseases. Results. The medical records of 3 families of a 4-generation pedigree
affected by North Carolina macular dystrophy were reviewed. A total of 8 patients with Stargardt disease were evaluated for their
twomain defining clinical characteristics, yellow subretinal flecks and central atrophy. Ninemale patients with a previous diagnosis
of choroideremia and eleven female carriers were evaluated. Fourteen patients with Best vitelliform macular dystrophy and 6
family members with autosomal recessive bestrophinopathy were included. Seven patients with enhanced s-cone syndrome were
ascertained. Lastly, we included 3 unrelated patients with fundus albipunctatus. Conclusions. In hereditary retinal diseases, clinical
examination is often not sufficient for evaluating the patient’s condition. Retinal imaging then becomes important in making the
diagnosis, in monitoring the progression of disease, and as a surrogate outcome measure of the efficacy of an intervention.
1. Introduction
Evaluation of the retina is a critical step in understanding and
diagnosing genetic disease. Because ophthalmologists can
view the retina directly, they are often able to make diagnoses
without additional testing. In a number of diseases, however,
the clinical examination is not sufficient for evaluating the
patient’s condition. Retinal imaging then becomes important
inmaking the diagnosis and inmonitoring the progression of
disease. It may be used to document and quantify a patient’s
symptoms; it may help in making a differential diagnosis of
some retinal disorders, in distinguishing localized macular
disorders fromdiffuse retinal disorders, and in distinguishing
optic nerve disease from retinal disease. Early alteration of
retinal imaging might serve as a surrogate outcome measure
of the efficacy of an intervention, rather thanwaiting for years
to determine if a disease has progressed clinically.
Diagnostic imaging procedures used for evaluation and
followup of retinal genetic disease include colour fundus
photography, blue fundus autofluorescence (FAF) [1–3], fluo-
rescein angiography (FA) [4, 5], indocyanine green angiog-
raphy (ICGA) [6], and spectral-domain optical coherence
tomography (SD-OCT) [5, 7, 8].
We evaluate here the multimodal visualization of retinal
genetic diseases and correlate FAF, FA, and ICG of study
lesions with SD-OCT to assess their ultrastructural charac-
teristics and to better understand the natural course of the
diseases [7].
2. Methods
We reviewed the charts of 70 consecutive patients with differ-
ent genetic retinal pathologies visited at the Ocular Genetic
Department of the Sant’Orsola-Malpighi Hospital, Bologna,
between January 2008 and December 2012. Only eyes having
previously undergone multimodal imaging analyses (high-
resolution digital colour fundus photographs, FAF, FA, ICGA,
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and SD-OCT) were included. All patients underwent a com-
plete ophthalmologic examination, including measurement
of best-corrected visual acuity (BCVA) using standard Early
Treatment of Diabetic Retinopathy Study (ETDRS) charts,
slit lamp examination of the anterior segment, and fundus
biomicroscopy. Colour fundus photographs were obtained
using a high-resolution digital retinal camera (Topcon
TRX-50 retinal camera; Tokyo, Japan). For high-resolution
multimodal fundus imaging analysis, we used a combined
instrument (Spectralis HRA-OCT, Heidelberg Engineering,
Heidelberg,Germany) that allows for simultaneous recording
of cSLO and SD-OCT images. A standardized imaging proto-
col was performed in all patients, which included acquisition
of blue FAF and FA (excitation 𝑘 = 488 nm; emission 𝑘 >
500 nm; field of view, 30∘ ⋅ 30∘; image resolution 768 ⋅ 768
pixels), simultaneous SD-OCT scanning using a second,
independent pair of scanning mirrors (𝑘 = 870 nm; acquisi-
tion speed, 40.000 A-scans per seconds; scan depth, 1.8mm;
digital depth resolution, approximately 3.5 𝜇m per pixel;
optical depth resolution, 7𝜇m; lateral optical resolution,
14 𝜇m), and indocyanine green angiography (excitation 𝑘 =
787 nm; emission 𝑘 > 800 nm; field of view, 30∘ ⋅ 30∘; image
resolution, 768 ⋅ 768 pixels) [7]. Fundus autofluorescence, FA,
ICGA, and SD-OCT images were evaluated on a computer
monitor by two independent examiners (F.P. and M.M.).
Genomic DNAwas extracted from peripheral blood with
the Qiagen Blood DNA extraction kit (Qiagen, Crawley,
UK) and genotyped at the known locus for the different
diseases using short tandem repeat polymorphisms [9]. DNA
samples were subsequently examined with a genome-wide
scan of single nucleotide polymorphisms and the genotypes
that were produced were studied with linkage and haplotype
analyses [10].
3. Results
3.1. North Carolina Macular Dystrophy (NCMD). The med-
ical records of 3 families of a 4-generation pedigree were
reviewed; the first recorded examination period took place in
2009, and the last took place in 2012. Twelve members were
found to be clinically affected with NCMD. Macular findings
among the affected patients ranged from disease grade 1 (6
eyes, mean age 57 years old) to grades 2 (8 eyes, mean age
44 years old) and 3 (10 eyes, mean age 19 years old) (Figure 1).
All affected patients had symmetric disease grades bilaterally;
when first examined, those with disease grade 2 had amedian
VA of 20/25 and those with disease grade 3 had a median VA
of 20/60. In addition, all affected familymembers had numer-
ous yellow, midperipheral drusen-like deposits in both eyes.
Genetic testing of family members mapped the responsi-
ble mutation to theMCDR1 locus on chromosome 6 between
the markers D6S1609 and D6S1627.
Grade 1 lesions showed clusters of peculiar, yellow-white
spots at the level of the RPE; angiography revealed a pattern of
hyperfluorescence that was apparent in the arterial phase and
did not change during the course of angiography.The drusen-
like lesions could not be picked up by SD-OCT, but where
hyperautofluorescent, suggesting a lipofuscin composition
(Figure 1(a)).
Grade 2 lesions consisted of substantial disciform scar-
ring, often resulting from CNV; autofluorescence imaging
showed a ring of increased autofluorescence, surrounded by
a ring of decreased autofluorescence corresponding to the
ring of mottled RPE. Spectral domain OCT showed loss of
architecture of the outer retina due to fibrotic CNV, without
activity on FA (Figure 1(b)).
Grade 3 lesions consisted of excavated atrophic chori-
oretinal lesions with an overhanging lip of retina that partly
surrounded these lesions; these features were confirmed by
autofluorescence, that showed loss of central autofluores-
cence with a ring of hyperautofluorescence at the edge of
the lesions. Angiography revealed the presence of only a
few small choroidal blood vessels in the area of the macular
lesions, surrounded by subretinal fibrosis (Figure 1(c)).
3.2. Stargardt Disease. A total of 16 eyes (8 patients) with
Stardardt disease were retrospectively reviewed; there were 5
women and 3menwith amean age at presentation of 39 years
(range 17–46 years). Best-corrected visual acuity ranged from
20/20 to 20/400, with a mean of 20/80.
Two main defining clinical characteristics of the disease
were identified in our patients: 7 eyes (43.7%) presented with
yellow subretinal flecks, 5 eyes (31.2%) showed central atro-
phy, and 4 eyes (25.1%) a combination of the previous lesions.
On colour fundus photography, the retinal flecks pre-
sented heterogeneous patterns, which were perifoveal or
widely distributed in the fundus (Figure 2). Flecks cor-
responded on FAF imaging to areas where the autofluo-
rescence signal differed from the overall background level
(Figure 2(b)). Most flecks seen on FAF were hyperautoflu-
orescence, whereas some were surrounded by a ring of
decreased autofluorescence. On FA the characteristic pisi-
form flecks were hypo- or hyperfluorescent (Figure 2(d)).
Spectral Domain OCT scans through the flecks clearly
revealed 2 patterns, as described by Querques et al. [11].
Type 1 deposits are dome shaped and located at the level
of or just above the RPE; type 1 deposits were observed in
91% of our patients (Figure 2(b), square a). Type 2 deposits
presented as small, linear hypoerreflective lesions located at
the level of the inner segments of photoreceptors or outer
nuclear layer (ONL) and clearly separated from the RPE; type
2 lesions were observed in 84% eyes (Figure 2(b), square
b). The number of flecks located in the macula increased
radially exhibiting a pattern of centrifugal addition beginning
from the fovea and extending toward the outer edges of
the macula; newer flecks appeared hyperautofluorescent on
FAF imaging, while older flecks become progressively more
hypoautofluorscent with time.
Central atrophy corresponded to a clearly demarcated
area of uniform decreased autofluorescence surrounded by
a border of patchy, mottled hypoautofluorescence (Fig-
ure 2(b)); the sharply demarcated areas of central atrophy
gradually enlarged in 3 eyes, and new areas of atrophy
appeared to emerge and extend selectively into locations
demonstrating mottled hypoautofluorescence. Angiography
demonstrated perifoveal window defect, corresponding to
dropout of RPE cells, and visualization of the large choroidal
vessels centrally (Figure 2(d)).




Figure 1: Fundus photographs of affected patients with North Carolina macular dystrophy, showing fine, confluent drusen in the macula
(grade I), a subretinal scar due to a prior choroidal neovascularization (Grade II), and a macular caldera (Grade III). In Grade I
lesion, autofluorescence shows marked hyperautofluorescence of the bright drusen-like elements. SD-OCT shows a normal anatomy of
the inner retina; the photoreceptor-retinal pigment epithelium complex appears normal, and the drusen-like lesions are not detectable.
In Grade II lesion, SD-OCT shows increased reflectivity consistent with subretinal fibrosis or gliosis. In the Grade III lesion, fundus
autofluorescence demonstrates central hypoautofluorescence, surrounded bynormal appearing retina tissue andpreserved foveal tissue.There
is a hyperautofluorescent perimeter surrounding the edges of the lesion, possibly indicative of metabolic byproduct deposition. SD-OCT
demonstrates a normal hyperreflective IS/OS photoreceptor junction with abrupt attenuation of outer retinal structures and RPE absence
within the lesion.
An angiographically dark choroid was noted in 62% of
our patients (Figure 2(d)); the lack of early choroidal flush is
thought to be due to blocking of choroidal fluorescence by a
diffuse accumulation of lipofuscin in the RPE.
3.3. Choroideremia. Medical records of nine male patients
with a previous diagnosis of choroideremia were reviewed;
mean age was 23 years old, and mean BCVA at presentation
was 20/30. The disease was bilateral and symmetric in 9/9
(100%) patients. Three patients (33.3%) showed midperiph-
eral RPE abnormalities, which in 5 patients (55.5%) had
already spread peripherally with involvement of the choroid
too and visualization of coursing large choroidal vessels;
one patient (11.1%) presented with vascular attenuation and
optic atrophy (Figure 3). The fovea was spared in every case.
In 100% of the patients, FA showed filling of the retinal
and large choroidal vessels, but not of the choriocapillaris.
The intact fovea was hypofluorescent and surrounded by
a hyperfluorescence stellate preservation of the posterior
pole due to an extensive window defect. Zonal areas of
peripheral atrophy were accentuated on the FAF as areas of
hypoautofluorescence, which contrasted with the physiolog-
ical autofluorescence of the fundus (Figure 3(b)). Spectral
domainOCT scans showeddiffuse choroidal atrophy and loss
of the IS/OS junction, which was intact and preserved at the
level of the fovea (Figure 3(c)).
Eleven female carriers of the 9 independent families were
examined, 9mothers and 2 sisters.MeanBCVAwas 20/25. All
carriers (100%) showed mild, patchy peripheral RPE atrophy
and mottling with a striking speckled pattern in FAF and
simultaneous choroidal and retinal filling in FA (Figures 3(d),
3(e), 3(f), and 3(g)).
3.4. Bestrophinopathies . Fourteen patients with Best vitelli-
form macular dystrophy (BVMD) were included. The mean
age of enrolled subjects was 37 years (range 9 to 59 years).The
median BCVA was 20/50 (range 20/20 to 20/320).
In 2 patients with a positive family history of BVMD, clin-
ical evaluation showed RPE mottling and SD-OCT imaging
demonstrated a prominent highly reflectivematerial between
the RPE/Bruch’s membrane complex and the IS/OS junction
(previtelliform stage, Figure 4(b)).
In 5 patients, an elevated yellow round macular lesion
measuring approximately 3/4 disc diameter across was found
in the fundus. On SD-OCT imaging, the foveal retinawas ele-
vated due to a homogeneous hyperreflective material located
just above the RPE. The hyperreflective material presented
increased fluorescence on FAF (vitelliform stage, Figure 4(a)).
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Figure 2: Color photograph shows macular atrophy and retinal flecks in a Stargardt patient. OCT scans are illustrated by the arrows 1 and
2. The autofluorescent frame clearly delineates the retinal flecks. Thin and open arrows point to two of the flecks, respectively, crossed by
scans 1 and 2. Fluorescein angiography shows the dark choroid appearance, and the hypofluorescent flecks are hardly discernable in the
hyperfluorescent background because of RPE changes. On ICG, late phase (30min), the hypofluorescent lesions appear more numerous
than the autofluorescent flecks, and there is sparing of the peripapillary area. The SD-OCT scan in square A shows a small hyperreflective
lesion located at the inner part of the RPE layer, called type 1 deposit, and macular atrophy. The SD-OCT scan in square B shows a small
hyperreflective linear lesion located at the level of the outer nuclear layer and clearly distinguished from the RPE layer, called type 2 deposit.
In 4 patients, an elevated oval macular lesion measuring
approximately three disc diameters across was observed in
both eyes. A yellowish material located more prominently at
the inferior aspect of the lesion was evident. In the center
of the macula, SD-OCT imaging showed separation of the
neurosensory retina from the RPE by an optically clear
space and clumps of homogeneous hyperreflective material
overlying the RPE inferiorly displaced. On FAF, increased
autofluorescence from the hyperreflective material overlying
the RPE was observed from the inferior aspect of the lesion
(pseudohypopyon stage, Figure 4(c)).
In 3 patients elevated macular lesions, with variable
amounts of yellowish subretinal material dispersed within,
were observed. SD-OCT imaging showed the neurosensory
retina separated from the RPE centrally by an optically clear
space, photoreceptors’ OS irregularly elongated, and hyper-
reflective mounds at the level of the RPE, clearly delineated
on FAF (vitelliruptive stage, Figure 4(d)).
Two of the previous patients had family members with
DNAsamples available for study, and in each of these families,
the disease causing variations were found to lie on separate
alleles, consistent with autosomal recessive bestrophinopathy
(ARB). Six patients with ARB from 2 nonconsanguineous
families were therefore reviewed. All patients had bilateral
maculopathy with subretinal yellow deposits. Subretinal
deposits in subjects 3 to 6 weremore prominent, appearing as
multifocal, round, yellow lesions surrounding amacular neu-
rosensory retinal detachment (Figures 5(a) and 5(d)). Similar
additional areas of 2 to 3 disc diameters were present above
the optic discs. In all patients, fundus autofluorescence imag-
ing displayed marked hyperautofluorescence corresponding
to the yellow lesions (Figures 5(c) and 5(f)). In subject 2, this
identified additional peripapillary hyperfluorescent deposits
not seen on funduscopy. Spectral-domain optical coherence
tomography scans demonstrated round- or dome-shaped
deposits within the RPE reaching into the subretinal space in
all subjects, which extended up to the OPL (Figure 5(b)).The
RPE itself was thinned throughout themacula. Photoreceptor
outer segments were thicker and elongated compared with
normal control data. Small filament-like bridges were visible
between the photoreceptor outer segment layer and the RPE
(Figure 5(e)). Verhoeff ’s membrane, the interface between
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Figure 3: Fundus photograph of a male patient affected by choroideremia shows midperipheral RPE atrophy spreading peripherally with
visualization of coursing large choroidal vessels and sparing of the fovea. Fundus autofluorescence demonstrates an hyperautofluorescent
stellate preservation of the posterior pole. Spectral-domain OCT scans show diffuse choroidal atrophy and loss of the IS/OS junction, which
is intact and preserved at the level of the fovea. The boy’s mother was a genetically confirmed female carrier: her fundus shows mild, patchy
peripheral RPE mottling with a striking speckled pattern in FAF.
(a) (b)
(c) (d)
Figure 4: Spectral domain-OCT scans document the natural evolution of BVMD. Firstly a thicker layer between the photoreceptors
inner/outer segment interface and the underlying RPE (previtelliform stage).Thematerial is subsequently deposited under the neurosensory
retina (vitelliform stage) and is sometimes accompanied with a neurosensory detachment (pseudohypopyon stage) secondary to its
reabsorption, with abnormalities of the RPE and subsequent thinning of all retinal layers (vitelliruptive and atrophic stage).
cone photoreceptors and theRPE,was not identifiable inmul-
tiple scans. Inner retinal layers were unaffected. All subjects
harbored compound heterozygous mutations in BEST1; the
2 most frequent recessive alleles observed in our series were
Arg141His (3 patients) and Ala195Val (2 patients), whereas
one patient had an Arg92Cys mutation.
3.5. Enhanced S-Cone Syndrome (ESCS). Seven patients with
ESCS were ascertained. The clinical presentation in all
patients was night blindness, with or without reduced central
vision. Nyctalopia had begun in early childhood with onset
ranging from 2 to 6 years of age. No patient reported
photophobia. Visual acuity ranged between 20/20 and 20/80.
Nystagmus was not present in any patient. Vitreous cells
were present in all patients. The fundus appearance varied
between patients.The youngest subject had normal appearing
fundi. Six patients had subtle to mild pigmentary changes
with nummular pigmentary deposition at the level of the
RPE, usually located in the midperiphery along the vascular
arcades and often associated with RPE atrophy, with one of
these subjects having small yellow-white dots at the posterior
pole (Figures 6(a) and 6(e)). Foveal schisis-like changes were
observed in 6 patients. OCT demonstrated foveal cyst for-
mation (Figures 6(d) and 6(h)). Subsequently, these patients
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Figure 5: Fundus photograph of an autosomal recessive bestrophinopathy shows a well-demarcated area with round yellowish-white deposits
at the posterior pole and along the superotemporal arcade; subretinal fibrosis is visible inferior nasal of the fovea. SD-OCT scan illustrates
extensive RPE deposits extending to the outer plexiform layer. Fundus autofluorescence imaging displayed marked hyperautofluorescence
corresponding to the yellow lesions. Fundus photograph shows a well-demarcated area with round yellowish-white deposits at the posterior
pole extending to the superior periphery. SD-OCT scan demonstrates RPE detachment from the photoreceptors. Photoreceptor outer
segments are thickened and elongated. Fundus autofluorescence identified additional peripapillary hyperfluorescent deposits not seen on
funduscopy.
(a) (b) (c) (d)
(e) (f) (g) (h)
Figure 6: Color fundus photography of a patient with enhanced s-cone syndrome showing nummular pigmentary clumping at the level of
the RPE along the vascular arcades and macular disturbance with subtle pigmentary changes; fundus autofluorescence shows an absence of
AF outside the arcades and a ring of increased AF at the posterior pole. Foveal schisis is demonstrated on SD-OCT and confirmed by the
absence of leakage on fluorescein angiography.
had FA, which showed no leakage, suggesting that the cystoid
changes were more likely to be secondary to schisis than
to edema (Figures 6(b) and 6(f)). Fundus autofluorescence
showed a decrease or lack of autofluorescence outside the
arcades, a ring of relatively increased autofluorescence in
the transitional zone between this area of decreased/absent
autofluorescence and the macular region, and a spoke-like
area of relatively increased autofluorescence centered on the
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Figure 7: Fundus photograph of two eyes with fundus albipunctatus shows many small white dots scattered throughout the retina except for
the foveal area. Fundus autofluorescence imaging of both eyes produced fuzzy and grainy images, and themargins of the optic nerve head and
blood vessels are blurred. On SD-OCT, focal thickening centered in the photoreceptor OS and extending forward close to the outer limiting
membrane and backward to the outer aspect of the RPE is seen corresponding to the multiple discrete albipunctate dots. These lesions seem
to bulge their outer and inner boundaries. There was a reduced visualization of the photoreceptor outer tips.
fovea (Figures 6(c) and 6(g)). Mutations were identified in 7
of 7 subjects.Three previously reportedmutations were iden-
tified, a splice acceptor intron 1 mutation (IVS1-2A>C splice
site) with the Arg311Gln (R311Q) and Arg104Trp (932G→A;
exon 6substitutions) and the 481delA frameshift mutation.
3.6. Fundus Albipunctatus. We included 3 unrelated patients
(aged 20, 35, and 8 years) with fundus albipunctatus.
All patients had diffusely scattered white round flecks
scattered in a radial pattern from the vascular arcades
throughout the retina, except for the foveal area (Figures
7(a) and 7(d)). Mean BCVA was 20/25, and the results of
the ocular examination were normal except for the fundus.
Spectral domain OCT revealed an irregular IS band through
the macula and a dome-shaped elevation corresponding
to discrete albipunctate dots (Figure 7(c) and 7(f)). These
elevated lesions were at the level of the RPE and extended
into the IS band and external limiting membrane. The ONL
thickness was thinner than that in normal controls. In 2/3
patients the FAF image was fuzzy and grainy, and themargins
of the optic nerve head and blood vessels were blurred. No
enhanced hyperautofluorescent spots or rings, which may
correlate to the albipunctate spots on the fundus photo, were
observed. Whereas fundus autofluorescence was scarcely
detectable in the 2 oldest patients, it was severely reduced in
the youngest (Figures 7(b) and 7(e)) but still detectable.
Two patients harbored homozygous mutations (c.881G.C
and c.382G.A, resp.) and the third patient harbored the
compound heterozygous mutations (c.95delT and c.712G.T)
in RDH5.
4. Discussion
This study reports a comparison between FAF, FA, ICGA, and
OCT for imaging of genetic retinal diseases.
North Carolina macular dystrophy is an autosomal dom-
inant macular dystrophy with variable expressivity but com-
plete penetrance that rarely progresses [12, 13]. Visual acuity
is often better than expected from the clinical examination of
the macula, ranging from 20/20 to 20/200, with a median of
20/50. Color vision, full-field electroretinography, and elec-
trooculography results typically are normal. North Carolina
macular dystrophy is unusual in its phenotypic variability and
has been classified into different grades: grade 1, drusen-like
yellow-white lesions in the macula at the level of the retinal
pigment epithelium (RPE); grade 2, confluent drusen with
or without pigmentary changes, RPE atrophy, or a disciform
scar; and grade 3, staphyloma or colobomawith chorioretinal
atrophy [13–15] (Figure 1). In grade 3 disease, hyperpigmen-
tation and heaped-up white scar tissue are seen at the edge
of the macular lesion. Development of choroidal neovascu-
larization is uncommon but can worsen otherwise relatively
stable visual acuity. Although grade 3 macular lesion is
characteristic of NCMD, there has been much confusion in
the literature regarding its nomenclature and 3-dimensional
configuration. Small et al. [14] originally described these
lesions as colobomas. Frank et al. [16] further studied this
family and called these lesions choroidal atrophy, thereby
creating some controversy. Gass [17] later described other
members with NCMD as being “staphylomatous appearing.”
Small et al. [13] reexamined the original family and concurred
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with Gass, because the cases were “clearly excavated, colobo-
matous, or staphylomatous in appearance when examined
with binocular methods”. Subsequently, grade 3 lesions were
labeled and characterized as colobomas or staphylomas in
the literature [15]. However, terms such as coloboma and
staphyloma clearly are misnomers; coloboma refers to an
absence of tissue that had never been present, and staphyloma
refers to an outpouching of the sclera that is lined with uveal
tissue. On review of the published literature, there has never
been proof of staphyloma formation by ultrasound. In the
patients with staphylomatous changes, SD-OCT showed no
outpouching of the scleral tissue. Instead, on biomicroscopic
and binocular ophthalmoscopic examination, there is an
illusion of outpouching because of the heaped-up subretinal
gliosis and fibrosis surrounding the zone of atrophy in a
curvilinear pattern. Khurana et al. [15] agree with Small’s
initial observation of a “posterior bowing of the central
macula that produced a crater-like or staphylomatous appear-
ance. The sharply demarcated temporal edge has a ledge or
overhang affect”. Khurana proposed a new term for these
grade 3 lesions, macular caldera. Caldera refers to a craterlike
volcanic feature formed by the central collapse of land after
a volcanic eruption. In our series, the SD-OCT scans of the
10 eyes with grade 3 lesions show the excavation centrally
with the subretinal fibrous or gliotic tissue surrounding the
atrophy, confirming that the term coined by Khurana might
describe the best this lesion (Figure 1(c)). Although the
pathogenesis of these grade 3 lesions is not known, Khurana
proposed the following possible mechanism to describe the
caldera formation. In NCMD, pathologic processes similar to
those of AMD seem to begin in utero. In some cases, CNV,
RPE tears, macular hemorrhaging, and eventually disciform-
type lesions with fibrosis, gliosis, or both may occur. The
characteristic greyish-white, heaped-up subretinal tissue that
occurs at the border of the profound macular atrophy may
be secondary to eruptive hemorrhaging and, subsequently,
to accentuated fibrosis and gliosis and scar tissue formation.
As the hemorrhage becomes organized, the authors speculate
that the tremendous, inherent growth potential that charac-
terizes virtually all fetal and neonatal tissues could result in
the circumferential, heaped-up hyperplastic or hypertrophic
subretinal scar.
ABCA4 is the only gene known to cause autosomal reces-
sive Stargardt disease. Localized to the rims of rod and cone
outer segments, ABCA4 gene product (an ATP-binding cas-
sette transporter) normally transports all-trans-retinol pro-
duced in light exposed photoreceptor outer segments to the
extracellular space [11, 18]. When a mutation in the ABCA4
gene results in a dysfunctional protein, A2E (N-retinylidene-
N-retinyl-ethanolamine), derived from the retinoid compo-
nent of photopigment accumulating from photoreceptor OS
debris, accumulates within the photoreceptors outer segment
cell membrane. Adjacent RPE cells then phagocytose shed
photoreceptor outer segments engorged with cytotoxic A2E,
and large amount of intracellular A2E quickly accumulates,
with flecks formation.The accumulation of flecks in Stargardt
patients in our series progressed spatially from the fovea in a
radial pattern, suggesting that the earliest events leading to
fleck formation occur close to the fovea [19]. Fleck lesions
on FAF imaging were observed to increase in hyperaut-
ofluorescence, reach a peak, then decrease subsequently in
autofluorescence to near-background levels, and eventually
become hypoautofluorescent. The hyperreflective deposits at
the level of the ONL (type 2) could be the residual cover
of the dome-shaped lesions (type 1). This latter hypothesis
is consistent with the natural history of the flecks, which
progressively degrade, from a well-defined lesion to residual
material.
A2E laden RPE exhibits impaired degradation of phos-
pholipids, which induces the release of proapoptotic proteins
from mitochondria [18] and deterioration with the break-
down of cellular membranes and the ultimate lysis and death
of RPE cell which may culminate in atrophy. ICGA may
provide useful information about alterations of the choroid
and the choriocapillaris [11]. The finding of hypocyanescence
by ICGA in advanced disease (“dark atrophy” as previ-
ously described by Giani et al.) may be due to extended
damage to choriocapillaris [20]. Moreover, the absence of
normal choroidal hyperfluorescence by FA in the final stages,
described by Yzer et al. [21] as “choroidal silence,” is due
to marked atrophy of the choriocapillaris, which is a direct
consequence of RPE absence. The choroid under the areas of
atrophy seems to be morphologically intact.
Dark choroid is characterized by the absence of normal
background fluorescence mainly due to the presence of RPE
lipofuscin that absorbs the blue excitatory light [20].
Choroideremia is caused by mutations in the CHM gene
localized to the long arm of X-chromosome (Xq21.2). The
mutation affects the production of Rab escort protein isoform
1 (REP-1), the enzyme that plays a key role in the activation
of Rab proteins that are responsible for the regulation of
exocytic and endocytic cellular pathways. Boys have difficulty
seeing at night in the first decade of life and then become
aware of loss of peripheral vision by their teens. Areas of RPE
disruption throughout the fundus are early clinical manifes-
tations in a male patient with choroideremia (Figures 3(a),
3(b), and 3(c)). The progressive retinal changes in choroi-
deremia can be described by careful analysis of SD-OCT
images [22]. In the early phase, retinal thickening occurs
with normal laminae, possibly due to Mu¨ller cell activation
and hypertrophy creating interlaminar bridges. Late phases
show shortening of the inner and outer segments, reduced
thickness of the outer nuclear layer, and depigmentation
of the RPE. Areas of chorioretinal atrophy become evident
over time with loss of choriocapillaris, exposure of choroidal
vessels, and loss of the RPE beyond the macula. In most cases
central visual acuity is well maintained until quite late in the
course of the disease, despite substantial loss of peripheral
vision and significant chorioretinal degeneration [22].
Female choroideremia carriers can be identified clinically
by the presence of patchy areas of RPE atrophy (Figures
3(d), 3(e), 3(f), and 3(g)) [23]. Fluorescein angiography has
been advocated as a supplemental examination to detect
female carriers by demonstrating window defect in the RPE.
Furthermore, instead of an initial appearance of a choroidal
flush, the choroidal circulation is delayed such that the
retinal circulation and the choroidal circulation appear to
fill simultaneously [24]. Fundus autofluorescence provides
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predictive information for the detection of female carriers.
A characteristic pattern of granular high-density FAF with
low-density fluorescence spots was present throughout the
examined area in the female carriers included in this study.
This pattern is due to the fact that the CMH gene product
(REP1) is localized in rods and RPE cells, but not in cones
[24]. Therefore, a patch of degeneration in a CMH carrier
fundus may either arise from a clone of rod cells or RPE cells
with the inactivated wild-type REP1 gene; X-linked disorders
show independent degeneration of RPE cells and rods show
irregularly distributed changes of hypo- (degenerating RPE)
and hyperautofluorescence (degenerating rods).
Best vitelliformmacular dystrophy was the first inherited
retinal condition in which mutations in the BEST1 gene were
shown to be the underlying cause. Other mutations in the
same gene are known to cause ARB. Hence this group of
conditions is called bestrophinopathies. Common to all, the
primary pathogenetic mechanism seems to be situated at the
level of the RPE, with secondary photoreceptors involvement.
BVMD is caused bymissensemutation in theBEST1 gene,
located on chromosome 11q13 and containing 11 exons. BEST1
encodes bestrophin-1, a protein localized to the basolateral
surface of the RPE, where it forms chloride channels [25].
Even if fundoscopic appearance and progression of BVMD
have been fully described, and FA and ICGA do not add
any further significant information, the advent of novel
imaging techniques such as fundus autofluorescence has
confirmed that the yellowish intra- and subretinal material
is hyperautofluorescent, due to its high lipofuscin content
[26] (Figure 4). Data obtained with SD-OCT have suggested
that material seen on fundoscopy as vitelliform material
is located under the neurosensory retina rather than in
and under the RPE [27]. Tomographic scans firstly show a
thicker layer between the photoreceptors inner/outer seg-
ment interface and the underlying RPE (previtelliform stage).
Material is subsequently deposited under the neurosensory
retina (vitelliform stage) and is sometimes accompanied with
a neurosensory detachment (pseudohypopyon stage), with
abnormalities of the RPE and subsequent thinning of all
retinal layers (vitelliruptive and atrophic stages). On the basis
of OCT and FAF findings, Spaide et al. [27] has hypothesized
a pathogenetic mechanism: inadequate removal of subretinal
fluid leads to the physical separation of the photoreceptors
from the underlying RPE; this results in the progressive accu-
mulation of lipofuscin at the outer side of the neurosensory
retina due to shedding of the outer segment discs without
proper phagocytosis by the RPE cells; with time, atrophy of
the photoreceptors and thinning of the accumulated material
lead to a decrease of the hyperautofluorescence, eventually
damage to the RPE ensues.
ARB is due to compound heterozygous or homozygous
mutations in BEST1 and segregates as an autosomal recessive
trait [28]. ARB has been hypothesized to represent the
BEST1 null phenotype, with either very little or no functional
bestrophin-1 available to RPE cells. Patients withARBpresent
with slowly progressive central visual loss, hypermetropia,
irregularity of the RPE, and deep, scattered, white subreti-
nal deposits that characteristically hyperfluoresce on FAF
imaging [29] (Figure 5). Spectral-domain OCT shows RPE
deposits, photoreceptor detachment, elongated and thick-
ened photoreceptor OS, and preserved inner retinal layers.
Multimodal imaging of bestrophinopaties suggests a
regional difference in expression of the bestrophin protein
throughout the retina, with more protein being produced in
the retinal periphery compared to the macula. This differen-
tial expression may lead to a more pronounced relative lack
of functional bestrophin in the macula, which would explain
why the latter is predominantly affected in BVMD.
Enhanced s-cone syndrome is a rare, slowly progressive
autosomal recessive retinal degeneration related to mutation
in NR2E3. NR2E3 encodes a ligand-dependent transcription
factor that controls retinal progenitor cell fate. It promotes
differentiation and survival of rod photoreceptors by differ-
entially regulating transcription of rod- and cone-specific
genes either directly or indirectly through interaction with
other transcription factors. Mutation in NR2E3 is thought to
cause disordered photoreceptor cell differentiation, possibly
by encouraging default from the rod photoreceptor pathway
to the s-cone pathway, thereby altering the relative ratio
of cone subtypes [30]. Histopathologic data have reported
an absence of rods, but a two-fold increase in the cone
population, most of which were thought to be s-cones [31].
The retina was highly degenerated and disorganized. Pho-
toreceptors were found only in the central and far peripheral
regions. Densely packed cones were intermixed with inner
retinal neurons [32]. The increased number of cones in ESCS
is unique, since, as a group of disorders, the progressive
retinal dystrophies are usually characterized by a loss of
photoreceptors. The most typical ophthalmoscopic feature
in our series was the presence of nummular, midperipheral
pigmentary deposits at the level of the RPE (Figure 6). This
typical retinal appearance was associated with an absence of
FAF outside the vascular arcades, possibly relating to loss of
photoreceptors in this region. A ring of relatively increased
FAF in the transitional area between the region of absent FAF
and the central zone of relatively normal FAF was evident.
The increased FAF detected may be related to lipofuscin
accumulation secondary to RPE-photoreceptor dysfunction
in that area. Foveal schisis documented by FA and OCT was
present in 6/7 patients, in keeping with previous findings.The
typical nummular, midperipheral pigmentary changes are a
useful clinical sign, but are not a consistent finding, being
evident in 6/7 patients in the present series. The association
of these nummular pigmentary deposits with white-yellow
dots at the level of the RPE along the vascular arcades,
focal hyperpigmentation within the arcades, and foveal or
peripheral schisis is more suggestive of ESCS.
Fundus albipunctatus is considered to be a form of
congenital stationary night blindness because of the predom-
inant stationary nature of the disease and associated night
blindness. It is caused by mutations in RDH5, encoding
11-cis-retinol dehydrogenase [33], and leads to impaired
production of 11-cis retinal, restricting the photopigment
turnover and leading to reduced formation of lipofuscin [34].
Therefore, the retinas of 2 patients in our series have a grainier
appearance in FAF than normal retinas do [34, 35]. Recent
studies support that the RPE has an alternative pathway
involving RDH10 for the production of 11-cis-retinal, which
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can account for the delayed dark adaptation in patients with
fundus andmay explain the residual remaining FAF found in
the youngest of our patient [35].
The presumed accumulation of cis-retinol and cis-retinyl
esters in the RPE because of 11-cis-retinol dehydrogenase
deficiency is responsible for the formation of white flecks
in RDH5 mutation-associated fundus albipunctatus [36, 37]
(Figure 7). It is not clear, however, why such accumulation
should result in highly focal rather than diffuse accumulation
of material. Furthermore, SD-OCT at high spatial resolution
showed that the characteristic white flecks of the fundus are
located in the outer retina at a specific depth, namely, in the
photoreceptor inner andOS and RPE layers where the lesions
are interspersed between normal-appearing stretches of outer
retina, apparently bulging the outer limiting membrane [37].
In this study, we employed a digital retinal camera and
a SD-OCT system combined with a multimodal cSLO topo-
graphic imaging system to obtain color fundus photographs
and simultaneous recordings of cross-sectional SD OCT and
c-SLO images, to correlate FA, FAF, and ICGA images.
It should however be kept in mind that specialized retinal
function and electrophysiologic testing are still fundamental
to diagnose retinal genetic disease and to better understand
the roles of various genes in maintaining structure and the
function of the retina. For example, a normal fundus appear-
ance and imaging do not preclude someone from carrying the
disease BEST1 gene, and an electrooculogram (EOG) should
always be performed to look for a Lightpeak/Darkthrough ratio
generally less than 1.5 or 150%. As for ESCS, it must be noted
that ERG recordings firstly showed that the large a-waves
were nearly entirely driven by the s-cones, thus suggesting
for the first time that the hypersensitivity and hyperfunction
of the s-cone system were due to an increased number of s-
cones.
In conclusion, genetic diseases may target the rod sys-
tem or the cone system, together or independently, and
multimodal imaging and electrophysiologic testing may be
employed to determine the relative involvement of these two
systems. As various therapies, including gene replacement,
are proposed for these disorders, retinal function and imag-
ing testing should help determine whether these treatments
are beneficial in altering the natural course of a disease and
whether they adversely affect retinal function.
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